NIH launches clinical trials for long COVID; HHS office to coordinate federal response

Jul 31, 2023 - 03:03 PM
NIH research

The National Institutes of Health’s Researching COVID to Enhance Recovery (RECOVER) Initiative opened enrollment for clinical trials to evaluate the safety and effectiveness of at least four potential treatments for Long COVID in adults. The project expects to launch trials to test at least seven more treatments in coming months, informed by findings from its other research over the past two years.

“Recognizing that more than one solution is likely needed, we’ve taken the lessons learned from RECOVER participants to design rigorous clinical trial platforms that will identify treatments for persons with different symptom clusters to improve their function and well-being,” said Walter Koroshetz, M.D., director of the NIH’s National Institute of Neurological Disorders and Stroke.

In related news, the Department of Health and Human Services today officially launched its Office of Long COVID Research and Practice to coordinate and lead the federal response to Long COVID.
 

Related News Articles

Headline
CMS Administrator Oz and Deputy Administrator Brillman discuss agency’s focus on innovation, reducing waste
Centers for Medicare & Medicaid Services Administrator Mehmet Oz, M.D., and CMS Deputy Administrator and Director of Medicaid and CHIP Dan Brillman sat…
Headline
CDC releases report on flu, COVID-19 vaccination coverage for health care workers for 2024-25 respiratory season 
Flu and COVID-19 vaccination rates among all health care workers for the 2024-25 respiratory virus season was 76.3% and 40.2%, respectively, according to a…
Headline
Study estimates more than 155,000 uncounted COVID-19 deaths occurred early during pandemic 
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
CDC report highlights low use of COVID-19 antivirals among people 65 and older 
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
FDA issues guidance on wellness products, clinical decision support software
The Food and Drug Administration today released two guidance documents; one related to low-risk wellness products (including certain wearable devices) and the…
Headline
CDC report finds COVID-19 vaccine for children reduced chances of ED, urgent care visits
The Centers for Disease Control and Prevention Dec. 11 released a report that found last year’s version of the COVID-19 vaccine was 76% effective in preventing…